Filing Details
- Accession Number:
- 0000899243-20-032575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 19:05:08
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-02 19:05:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326190 | Altimmune Inc. | ALT | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409939 | John Gill | C/O Altimmune, Inc., 910 Clopper Road, Suite 201S Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Disposition | 2020-11-30 | 8,425 | $11.92 | 11,199 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
